Dr. Brad Ringeisen, Ph.D. - Executive Director, Innovative Genomics Institute (IGI) - Advancing Genome Research For A Better World by Unknown

Dr. Brad Ringeisen, Ph.D. - Executive Director, Innovative Genomics Institute (IGI) - Advancing Genome Research For A Better World

Written byUnknown
Narrated byUnknown
Length0h57m
Release dateJune 29, 2023
★★★★☆ 4.5 (1 ratings)

Free with Audible trial. Cancel anytime.

Listen to a Sample

Hear Unknown's narration on Audible.

Play Sample on Audible

Quick Facts

AuthorUnknown
NarratorUnknown
Runtime0h57m
PublishedJune 29, 2023
Rating★★★★☆ 4.5 / 5 (1 ratings)
CategoriesHealth & Wellness, Hygiene & Healthy Living, Science & Engineering, Science
FormatAudiobook (Digital)
PlatformAudible

About This Audiobook

Send us Fan MailDr. Brad Ringeisen, Ph.D. is the Executive Director of the Innovative Genomics Institute ( https://innovativegenomics.org/people/...

Why Listen to Dr. Brad Ringeisen, Ph.D. - Executive Director, Innovative Genomics Institute (IGI) - Advancing Genome Research For A Better World?

  • Expert narration by Unknown brings every character and scene to life across 0h57m of immersive audio.
  • Bestseller-quality story from Unknown, rated 4.5 stars by 1 listeners.
  • Free with your Audible trial — keep the audiobook forever even if you cancel.
  • Perfect for commutes, workouts, and relaxation. Listen anywhere, anytime.
Start Listening Free

Download: Dr. Brad Ringeisen, Ph.D. - Executive Director, Innovative Genomics Institute (IGI) - Advancing Genome Research For A Better World

Some links on this page are affiliate links. If you make a purchase through one of them, we may earn a small commission at no extra cost to you.

Dr. Brad Ringeisen, Ph.D. - Executive Director, Innovative Genomics Institute (IGI) - Advancing Genome Research For A Better World by Unknown is an immersive listening experience. Performed by Unknown with a runtime of 0h57m, you can start with a free trial that you can cancel at any time. The audiobook remains yours forever, even if you end the trial.